Royal Bank of Canada »

Pelthos Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Pelthos Therapeutics (PTHS) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $0 6 0.00

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Pelthos Therapeutics

AIGH Capital Management
Murchinson
Ikarian Capital
Boothbay Fund Management
Vanguard Capital Management
Cantor Fitzgerald, L. P.
J. Goldman & Co
Diadema Partners
Wexford Capital
Knott David M Jr
Citadel Advisors
Geode Capital Management
Pale Fire Capital SE
1492 Capital Management
Vanguard Fiduciary Trust

View all funds holding Pelthos Therapeutics